Home › Duchenne Muscular Dystrophy › Arkansas
Duchenne Muscular Dystrophy clinical trials in Arkansas
7 studies for Duchenne Muscular Dystrophy are looking for participants at sites in Arkansas.
Cities in Arkansas
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 3
Ages 7 to 11 · Men · Updated Sep 28, 2026 · NCT07160634A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 1
Ages 2 and older · Men · Updated Sep 11, 2026 · NCT04626674A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 1/2
Ages 0 to 17 · Men · Updated Jul 8, 2026 · NCT06138639A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
- Arkansas Children's Research Institute, Little Rock
RecruitingObservational study
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT07127978PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 1/2
Ages 2 to 7 · Men · Updated Jun 23, 2026 · NCT07429240Duchenne Electronic Health Record Study
- Arkansas Children's Hospital, Little Rock
RecruitingObservational study
All ages · All sexes · Updated May 27, 2026 · NCT07609394Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 1/2
Ages 4 to 18 · Men · Updated Dec 15, 2025 · NCT04906460From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.